Page last updated: 2024-10-26

doxapram and Clostridioides difficile Infection

doxapram has been researched along with Clostridioides difficile Infection in 1 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andersson, JA1
Peniche, AG1
Galindo, CL1
Boonma, P1
Sha, J1
Luna, RA1
Savidge, TC1
Chopra, AK1
Dann, SM1

Other Studies

1 other study available for doxapram and Clostridioides difficile Infection

ArticleYear
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    mBio, 2020, 03-10, Volume: 11, Issue:2

    Topics: Amoxapine; Animals; Clostridioides difficile; Clostridium Infections; Doxapram; Drug Repositioning;

2020